Dimethyl Fumarate Enteric-coated Capsules
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dimethyl Fumarate Enteric-coated Capsules, covering 2025-08-24 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) [Phase 4]